| 08:45 - 08:55 |
Welcome speech
|
Prof. Helge Seifert |
| 08:55 - 09:00 |
Prostate Cancer in Switzerland
|
PD Dr. Ashkan Mortezavi
On behalf of the Swiss Prostate Cancer Screening Working Group |
| |
Session 1 – Early detection
|
Chairs:
Prof. Per Anders Abrahamsson (Lund University) and
Prof. Cyrill Rentsch (Universitätsspital Basel) |
| 09:00 - 09:30 |
Prime time for organised, risk-adapted prostate cancer screening - Impact of the EU recommendations
|
Prof. Hein Van Poppel, Chair of the EAU Policy Office |
| 09:30 - 10:00 |
Prostate cancer screening, the current status in Europe: first results from the PRAISE-U project
|
Prof. Monique Roobol, Erasmus Medical Centre Rotterdam |
| 10:00 - 10:30 |
Early detection in the context of ProtecT: more harm than good?
|
Prof. Freddie Hamdy, Nuffield Department of Surgical Sciences,
University of Oxford |
| 10:30 - 11:00 |
Coffee break
|
|
| 11:00 - 11:30 |
Novel strategies for prostate cancer screening – the Stockholm trials
|
Ass. Prof. Tobias Nordström, PhD, Danderyd Sjukhus / Karolinska Institutet Stockholm |
| 11:30 - 12:00 |
Risk adapted PSA screening - first results from the PROBASE trial
|
Prof. Peter Albers, Heinrich-Heine-University Düsseldorf |
| 12:00 - 12:15 |
Discussion
|
|
| 12:15 - 13:15 |
Lunch
|
|
| |
Session 2 – Treating high risk non-metastatic prostate cancer
|
Chairs:
Prof. Derya Tilki (Martini Klinik Hamburg) and
Prof. Frank Stenner (Universitätsspital Basel) |
| 13:15 - 13:45 |
Role of PSMA PET CT for local staging of prostate cancer
|
Prof. Irene Burger, Kantonsspital Baden |
| 13:45 - 14:15 |
Identifying the optimal candidates for pelvic lymph node dissection during prostatectomy
|
Prof. Alberto Briganti, Università Vita-Salute San Raffaele, Milan |
| 14:15 - 14:45 |
Robotic prostatectomy for high risk locally-advanced prostate cancer: techniques and outcomes from the highest volume UK centre
|
Prof. Prabhakar Rajan, University College London Hospitals |
| 14:45 - 15:15 |
Coffee break
|
|
| 15:15 - 15:45 |
Surgery or radiotherapy for locally advanced prostate cancer
|
Prof. Piet Ost, Ghent University |
| 15:45 - 16:15 |
Treatment intensification for high-risk, locally advanced and N+ prostate cancer
|
Prof. Silke Gillessen, Oncology Institute of Southern Switzerland, EOC, Bellinzona |
| 16:15 - 16:30 |
Discussion
|
|
